What serious side effects should I watch for on semaglutide?

Seek urgent care for severe, persistent upper abdominal pain (especially with vomiting or pain radiating to the back), signs of gallbladder problems (right‑sided abdominal pain, fever, jaundice), inability to keep fluids down, signs of dehydration, vision changes, symptoms of low blood sugar if on insulin/sulfonylureas, or allergic reactions such as facial swelling or breathing difficulty.

Can semaglutide cause pancreatitis or gallstones?

Pancreatitis is rare but serious; stop the medication and seek urgent assessment if you have severe persistent abdominal pain, with or without vomiting. Gallstones and gallbladder inflammation can occur, partly related to rapid weight loss; report right‑upper‑quadrant pain, fever, pale stools or jaundice promptly.

How can I reduce semaglutide side effects?

Titrate slowly, don’t increase dose while symptomatic, eat smaller lower‑fat meals, prioritise hydration and electrolytes, avoid alcohol during bad nausea, consider ginger or prescribed anti‑nausea medicines if approved, and review other medicines that irritate the stomach. Work with your prescriber.

Is semaglutide safe in pregnancy or breastfeeding?

Semaglutide is not recommended in pregnancy or breastfeeding. If planning pregnancy, your doctor may advise stopping at least 2 months before conception due to the drug’s long half‑life.

Semaglutide Side Effects: Risks, Unknowns and Warning Signs

Q: What are the most common semaglutide side effects?

Nausea, vomiting, diarrhoea, constipation, abdominal pain or bloating, reflux/heartburn, decreased appetite, headache, fatigue and injection‑site reactions. These are usually dose‑related and tend to improve over weeks as your body adapts.

Q: Does semaglutide cause thyroid cancer?

Rodent studies showed thyroid C‑cell tumours with GLP‑1 RAs. A causal risk in humans has not been established. Semaglutide is contraindicated in people with personal/family history of medullary thyroid carcinoma (MTC) or MEN2. Speak to your doctor if you notice a neck lump, hoarseness or trouble swallowing.

Fast facts and red flags to know first

Most side effects are gastrointestinal and dose‑related (nausea, vomiting, diarrhoea, constipation, reflux).
Slow titration and smaller, lower‑fat meals usually reduce symptoms over time.
Serious but uncommon risks include pancreatitis, gallbladder disease, severe dehydration/acute kidney injury, and worsening diabetic retinopathy with rapid glucose improvement.
Do not use if you have a personal/family history of medullary thyroid carcinoma (MTC) or MEN2.

Seek urgent care now if you have severe persistent abdominal pain (with or without vomiting), right‑sided abdominal pain with fever or jaundice, inability to keep fluids down, fainting, trouble breathing, facial/tongue swelling, vision loss, or black/tarry stools.

Get side‑effect help

Common semaglutide side effects and typical timeline

Most people experience some digestive symptoms when starting or increasing the dose. These often improve after 2–8 weeks as your body adapts.

Gastrointestinal: nausea, vomiting, diarrhoea, constipation, bloating, abdominal pain, reflux/heartburn, dyspepsia, gas
Appetite and taste: reduced appetite, early fullness, altered taste
General: fatigue, headache, dizziness (especially with dehydration), injection‑site reactions (tenderness, small lump, redness)

Symptoms are more likely after dose increases and with large or high‑fat meals. Hydration and meal changes help (see the risk‑reduction section below).

Ask a clinician about your symptoms

Less common but important risks

Pancreatitis: severe persistent abdominal pain, often radiating to the back, with or without vomiting. Stop medication and seek urgent assessment.
Gallbladder disease (gallstones/cholecystitis): right‑upper‑quadrant pain, fever, nausea, pale stools or yellowing of the skin/eyes. Risk may rise with rapid weight loss.
Severe dehydration and acute kidney injury: from prolonged vomiting/diarrhoea or inadequate fluid intake. Monitor fluids and electrolytes.
Diabetic retinopathy complications: rapid glucose improvement can temporarily worsen eye disease in people with pre‑existing retinopathy. Arrange eye checks and report vision changes.
Hypoglycaemia: mainly when combined with insulin or sulfonylureas. Your doctor may reduce those doses.
Allergic reactions: rash, hives, facial/tongue swelling, breathing difficulty. Requires immediate medical attention.
Bowel obstruction or severe gastroparesis: escalating nausea/vomiting, inability to pass stool/gas, severe bloating. Rare but serious.
Thyroid C‑cell tumours in rodents: human relevance is uncertain. Contraindicated with MTC/MEN2; discuss neck lump, hoarseness or difficulty swallowing.

Discuss your risk factors

Who should avoid or use semaglutide with caution

Do not use: personal/family history of MTC or MEN2; hypersensitivity to semaglutide or excipients.
Use with caution and medical advice: prior pancreatitis; gallbladder disease; severe gastrointestinal disease (e.g., gastroparesis); significant kidney disease; advanced diabetic retinopathy; older age or frailty; adolescents (follow local indications).
Pregnancy and breastfeeding: not recommended. If planning pregnancy, doctors often advise stopping at least 2 months before conception.

Check if semaglutide is suitable for you

Interactions and absorption considerations

Delayed gastric emptying may affect absorption of some oral medicines. Your prescriber may adjust timing or monitor response.
In diabetes therapy, combining semaglutide with insulin or sulfonylureas increases hypoglycaemia risk; doses may need reduction and closer monitoring.
Alcohol can worsen nausea and pancreatitis risk. Limit or avoid, especially if symptomatic.

Ask about medicine interactions

How to lower your side‑effect risk

Titrate slowly: do not rush dose increases. Stay longer at a dose if you still have symptoms.
Adjust meals: choose smaller, more frequent meals; reduce very fatty or fried foods; pause eating at first sign of fullness.
Prioritise hydration: aim for regular water intake; consider oral rehydration/electrolytes if you have vomiting or diarrhoea.
Plan around dose day: schedule injections at a time that lets you rest if you feel unwell (e.g., evenings or weekends, as advised by your clinician).
Use supports if approved: ginger tea, prescribed anti‑nausea medicines, stool softeners or fibre for constipation (as clinically appropriate).
Pause dose escalations while symptomatic: stabilise before stepping up.

Get a personalised side‑effect plan

Brand‑specific notes: Ozempic, Wegovy and Rybelsus

Ozempic (injectable): approved for type 2 diabetes; sometimes used off‑label for weight loss. GI effects are dose‑dependent.
Wegovy (injectable): indicated for chronic weight management. Uses a step‑up dosing schedule to reduce GI symptoms.
Rybelsus (oral): tablet absorption can be affected by food and other medicines; take exactly as directed (usually on an empty stomach with a small amount of water).

Side‑effect profiles overlap across brands because the active ingredient is semaglutide; individual tolerance differs.

Not sure which brand suits you?

Unknowns and ongoing questions

Long‑term safety in non‑diabetic populations using higher doses for weight management is still being studied.
Impact of prolonged gastric emptying delay on nutrient status and certain oral medications requires ongoing monitoring.
Body composition: meaningful weight loss can include lean mass loss; structured nutrition and resistance training help protect muscle.
Mood changes and hair shedding have been reported by some users; clear causal links remain uncertain.

When to pause, stop, or seek urgent care

Pause and contact your prescriber: worsening GI symptoms after dose increase, persistent constipation (>3–4 days), signs of dehydration, or new vision changes.
Stop and seek urgent care: severe persistent abdominal pain (especially with vomiting or radiating to the back), right‑upper‑quadrant pain/fever/jaundice, inability to keep fluids down, fainting, chest pain, severe allergic reaction, or black/tarry stools.

Speak to a clinician today

Frequently asked questions

What are the most common semaglutide side effects?

Nausea, vomiting, diarrhoea, constipation, abdominal pain/bloating, reflux, decreased appetite, headache, fatigue and mild injection‑site reactions.

How long do side effects last?

Often 2–8 weeks after starting or increasing the dose, then they tend to improve. Do not escalate while symptomatic.

Does semaglutide cause thyroid cancer?

Rodent data showed C‑cell tumours; a causal human risk is unconfirmed. It is contraindicated with MTC or MEN2. Report new neck lumps, hoarseness or swallowing issues.

Can semaglutide worsen diabetic retinopathy?

Rapid glucose improvement may transiently worsen pre‑existing retinopathy. Eye checks and monitoring are recommended.

Is it safe to drink alcohol while taking semaglutide?

Alcohol can aggravate nausea and pancreatitis risk. Best limited or avoided, especially if you are symptomatic.

What if I can’t keep fluids down?

This is a red flag for dehydration and kidney injury risk. Seek medical care promptly.

Can semaglutide interact with my other medications?

Delayed gastric emptying may change how some oral medicines are absorbed. Review all medicines with your prescriber.

Is semaglutide suitable if I’ve had pancreatitis?

Use requires caution and specialist advice. New severe abdominal pain needs urgent assessment.

What should I read next?

See dosage guidance, benefits, results timeline, and brand‑specific side effect pages linked below.

Request tailored advice

Need help with semaglutide side effects?

Describe your symptoms and goals. A clinician can suggest safer next steps or alternatives.

If this is an emergency or you have severe symptoms, call 000 or seek urgent medical care.

Key takeaway

Semaglutide’s side effects are usually digestive and improve with careful dosing and simple lifestyle steps. Know the red flags, review your risk factors, and work closely with your prescriber to stay safe and get the intended benefits.

Get safe-use guidance